Home / Products / Cancer (Tumor) Cell Lines / RT-112/84
RT-112/84
Datasheet Protocol

RT-112/84

Cat. No. ARC0785
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Urinary bladder

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

RT-112/84 is a cancer cell line of urinary bladder carcinoma, isolated from in situ; urinary bladder.

Recommended Products

CPEB2 Knockout NCI-H1975 Polyclonal Cells CPEB2 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16842 CRIM1 Knockout jurkat Polyclonal Cells CRIM1 Knockout jurkat Polyclonal Cells Cat. No. ARG13167 CLDN1 Knockout DLD-1 Polyclonal Cells CLDN1 Knockout DLD-1 Polyclonal Cells Cat. No. ARG12064 APOBEC3A Knockout A549 Polyclonal Cells APOBEC3A Knockout A549 Polyclonal Cells Cat. No. ARG35602 IGF2BP3 Knockout CaSki Polyclonal Cells IGF2BP3 Knockout CaSki Polyclonal Cells Cat. No. ARG35941 CD81 Knockout HMY2-CIR Cell Line CD81 Knockout HMY2-CIR Cell Line Cat. No. ARG0422
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Urinary bladder
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
Unknown
Sex of Donor:
Female
Derived From Site:
In situ; Urinary bladder
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CAPN9 Knockout HAP1 Polyclonal Cells

CAPN9 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22254
 LCMT2 Knockout NCI-H1975 Polyclonal Cells

LCMT2 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16554
 CHML Knockout jurkat Polyclonal Cells

CHML Knockout jurkat Polyclonal Cells

Cat. No. ARG12828
 MRPL12 Knockout HEK293T Polyclonal Cells

MRPL12 Knockout HEK293T Polyclonal Cells

Cat. No. ARG3259
 SHG-44

SHG-44

Cat. No. ARC0814
 RKO

RKO

Cat. No. ARC0772